Table 1.

Baseline characteristics of the study patients

	Type D			Non–Type D			All P Valuea
	Current Smoker, n = 55	Stop Smoker, n = 23	P Valueb	Current Smoker, n = 18	Stop Smoker, n = 135	P Valueb
Age, y	63.4 ± 10.5	60.3 ± 11.4	NS	60.1 ± 13.6	63.7 ± 11.3	NS	NS
Male sex, %	22.1	9.9	NS	6.5	56.2	NS	NS
BMI, kg/m2	27.2 ± 3.4	28.1 ± 2.2	NS	27.7 ± 3.6	27.3 ± 4.5	NS	NS
SBP, mm Hg	142.3 ± 11.4	141.2 ± 10.9	NS	139.9 ± 12.2	141.5 ± 11.7	NS	NS
Heart rate, bpm	77.3 ± 2.4	75.7 ± 5.5	NS	79.1 ± 5.1	77.7 ± 4.9	NS	NS
Burden of CAD, %c	16.2 ± 7.6	15.4 ± 6.4	NS	14.7 ± 8.1	14.8 ± 5.5	NS	NS
LVEF, %	57.4 ± 3.3	58.2 ± 1.7	NS	57.1 ± 4.3	59.3 ± 2.2	NS	NS
Cholesterol, mg/dL	169.8 ± 43.6	171.4 ± 55.5	NS	171.4 ± 41.7	169.9 ± 43.7	NS	NS
HDL‐C, mg/dL	41.5 ± 10.1	50.2 ± 46.6	0.03	40.4 ± 15.5	45.4 ± 14.6	NS	NS
TG, mg/dL	119.4 ± 48.8	122.5 ± 58.4	NS	123.4 ± 46.2	118.5 ± 49.9	NS	NS
Fasting glucose, mg/dL	98.4 ± 11.1	101.3 ± 13.6	NS	103.3 ± 10.3	99.9 ± 12.1	NS	NS
Cr, mg/dL	0.9 ± 0.2	0.8 ± 0.6	NS	1.0 ± 0.2	0.9 ± 0.8	NS	NS
Age at onset of smoking, y	14.2 ± 3.8	16.8 ± 2.7	0.003	18.6 ± 8.8	16.6 ± 3.7	NS	0.001
Mean daily cigarettes, n	26.4 ± 14.3	24.6 ± 15.3	NS	26.9 ± 13.3	24.5 ± 11.1	NS	NS
Antiplatelet therapy, %	100	100	NS	100	100	NS	NS
Statin, %	98	99	NS	99	100	NS	NS
ACEI, %	95.2	96.6	NS	96.1	95.7	NS	NS
β‐Blocker, %	97.2	97.3	NS	98.1	97.4	NS	NS

Abbreviations: ACEI, angiotensin‐converting enzyme inhibitor; BMI, body mass index; CAD, coronary artery disease; Cr, creatinine; HDL‐C, high‐density lipoprotein cholesterol; LVEF, left ventricular ejection fraction; MANOVA, multivariate analysis of variance; NS, not significant; SBP, systolic blood pressure; SD, standard deviation; TG, triglycerides.

Data are presented as mean ± SD unless otherwise noted.

^aMANOVA between type D and non–type D groups.

^bMANOVA between current smoker and stop smoker groups.

^cCalculated as the ratio between degree of stenosis and number of vessels.